GENinCode

GENI · AIM · Health Care · mcap £5.5m · 0.7p 1 open situation →

EV: £3.5m
EV / EBIT: –
Net cash: £2.0m
FCF yield: -75.0%
Revenue: £2.6m
Share price 1y: −78%
Insiders 12m: no deals
Next report: around 7 Jun

Beta Briefing, track record and signals & risks are not ready for GENinCode yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation

dots = announcements

2026 Profit warning Placing of 47% of the market value Octopus Investments Limited selling down Profit warning Placing of 105% of the market value

Open · 1

Upgrade / downgrade cycle

Profit warning

profit warning · second in 12 months

GENinCode issued a profit warning on 29 Sep 2026; the shares moved −20% on the day. It is the second such statement in 12 months.

29 Sep 2026 profit warning · -20% on the day

Open the full view – chart and every step →

Closed · 4

Dilutive fundraisePlacing of 47% of the market value completed · 21 Jan 2026 – 8 Mar 2026 −58% OverhangOctopus Investments Limited selling down selling stopped · 12 Feb 2026 – 12 Feb 2026 −16% Upgrade / downgrade cycleProfit warning profit warning · 30 Sep 2025 – 29 Dec 2025 −74% Dilutive fundraisePlacing of 105% of the market value completed · 4 Jun 2025 – 4 Jul 2025 +100%

Company filings. Not investment advice.